VBI 9-Rated AmerisourceBergen Now On Our Radar
Let’s take a look at VBI 9-rated stock AmerisourceBergen, a pharmaceutical sourcing and distribution company that yields 2% as of this writing. We like AmerisourceBergen’s dividend growth story, strong free cash flow generation, guidance raise, and relatively low net debt load. We’ll also cover AmerisourceBergen’s downside risks as well as its upside potential. Shares appear undervalued as things stand today, with ABC trading below the low end of our fair value estimate range. By Callum Turcan Pharmaceutical sourcing and distribution company AmerisourceBergen (ABC) just popped up on our radar; its fundamentals are rock-solid and its technical readings indicate Wall Street is starting to take notice. The company just registered a 9 on the Valuentum Buying Index. This American healthcare company has consistently generated … Read more